General Information of the Protein
Protein ID
PT02568
Protein Name
Kallikrein-5
Secondarily
Protein Name
Kallikrein-like protein 2
Stratum corneum tryptic enzyme
Gene Name
KLK5
Secondarily
Gene Name
SCTE
UNQ570/PRO1132
Sequence
MATARPPWMWVLCALITALLLGVTEHVLANNDVSCDHPSNTVPSGSNQDLGAGAGEDARSDDSSSRIINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHCRKKVFRVRLGHYSLSPVYESGQQMFQGVKSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPINVSSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQIDDTMFCAGDKAGRDSCQGDSGGPVVCNGSLQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQETIQANS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Protease
>
Serine protease
>
Serine protease PA clan
>
Serine protease S1A subfamily
Function
May be involved in desquamation.
    Show/Hide
Uniprot ID
Primary ID:
Q9Y337

Secondarily ID:
A0A024R4G4
Q53ZR3
Q9HBG8
    Show/Hide
Ensembl ID
ENSG00000167754
HGNC ID
HGNC:6366
Subcellular Location
Secreted
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0569579
5-[2-[2-[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[2-[2-[2-[[(5S)-5-[[2-[[(3S,6S,9S,12S,15R,23R,26S)-15-[(2-aminoacetyl)amino]-6-(3-amino-3-oxopropyl)-9-(3-carbamimidamidopropyl)-12-[(1R)-1-hydroxyethyl]-3-[(4-hydroxyphenyl)methyl]-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosane-23-carbonyl]amino]acetyl]amino]-6-[(2-amino-2-oxoethyl)amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-4-carboxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-(hexadecanoylamino)-1-oxohexan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-2-oxoethoxy]ethoxy]ethylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
   Show/Hide
C143H199N27O45S2
 1
1
Ki = 1.2 nM
   TI
   LI
   LO
   TS
CP0970588
(5R,8S,11S,17S,20S,23S,26S,29S,32R)-32-[(2-aminoacetyl)amino]-23-(3-amino-3-oxopropyl)-17-(carboxymethyl)-26-[3-(diaminomethylideneamino)propyl]-29-[(1R)-1-hydroxyethyl]-8-(hydroxymethyl)-20-(1H-indol-3-ylmethyl)-7,10,16,19,22,25,28,31-octaoxo-3,34-dithia-6,9,15,18,21,24,27,30,40-nonazatricyclo[34.3.1.011,15]tetraconta-1(39),36(40),37-triene-5-carboxylic acid
   Show/Hide
C53H74N16O16S2
 1
1
Ki = 1.4 nM
   TI
   LI
   LO
   TS
CP0970168
(3S,6S,9S,12S,15S,18R,26R,29S,32S,35S)-18-[(2-aminoacetyl)amino]-9-(3-amino-3-oxo-propyl)-3-(carboxymethyl)-12-(3-guanidinopropyl)-15-[(1R)-1-hydroxyethyl]-32-(hydroxymethyl)-6-(1H-indol-3-ylmethyl)-29-isobutyl-2,5,8,11,14,17,22,28,31,34-decaoxo-20,24-dithia-1,4,7,10,13,16,27,30,33-nonazabicyclo[33.3.0]octatriacontane-26-carboxylic acid
   Show/Hide
C55H82N16O18S2
 1
1
Ki = 1.5 nM
   TI
   LI
   LO
   TS
CP0965124
(2S)-2-[[(3S,6S,9S,12S,15R,23R,26S)-15-[(2-aminoacetyl)amino]-6-(3-amino-3-oxo-propyl)-9-(3-guanidinopropyl)-12-[(1R)-1-hydroxyethyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosane-23-carbonyl]amino]butanedioic acid
   Show/Hide
C46H66N14O15S2
 1
1
Ki = 1.9 nM
   TI
   LI
   LO
   TS
CP0954572
(2S)-2-[[(5S,8S,11S)-11-[[(2S)-2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(5R,8S,14S,17S,20S,23S,26S)-26-[(2-aminoacetyl)amino]-17-(3-amino-3-oxopropyl)-20-(3-carbamimidamidopropyl)-23-[(1R)-1-hydroxyethyl]-14-(1H-indol-3-ylmethyl)-7,13,16,19,22,25-hexaoxo-3,28-dithia-6,12,15,18,21,24,34-heptazatricyclo[28.3.1.08,12]tetratriaconta-1(33),30(34),31-triene-5-carbonyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-8-[(1R)-1-hydroxyethyl]-7,10-dioxo-3,13-dithia-6,9,19-triazabicyclo[13.3.1]nonadeca-1(18),15(19),16-triene-5-carbonyl]amino]-3-methylbutanoic acid
   Show/Hide
C90H129N25O26S4
 1
1
Ki = 2 nM
   TI
   LI
   LO
   TS
CP0578483
(3S,6S,9S,12S,15R,23R,26S)-15-[(2-aminoacetyl)amino]-6-(3-amino-3-oxopropyl)-9-[3-(diaminomethylideneamino)propyl]-12-[(1R)-1-hydroxyethyl]-3-[(4-hydroxyphenyl)methyl]-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosane-23-carboxylic acid
   Show/Hide
C40H60N12O13S2
 1
1
Ki = 2.2 nM
   TI
   LI
   LO
   TS
CP0969324
(5R,8S,14S,17S,20S,23S,26S,29R)-29-[(2-aminoacetyl)amino]-20-(3-amino-3-oxopropyl)-14-(carboxymethyl)-23-[3-(diaminomethylideneamino)propyl]-26-[(1R)-1-hydroxyethyl]-17-(1H-indol-3-ylmethyl)-7,13,16,19,22,25,28-heptaoxo-3,31-dithia-6,12,15,18,21,24,27,37-octazatricyclo[31.3.1.08,12]heptatriaconta-1(36),33(37),34-triene-5-carboxylic acid
   Show/Hide
C50H69N15O14S2
 1
1
Ki = 2.7 nM
   TI
   LI
   LO
   TS
CP0970587
(2S)-2-[[(5S,8S,11S)-11-[[(2S)-2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(5R,8S,14S,17S,20S,23S,26R)-26-[(2-aminoacetyl)amino]-17-(3-amino-3-oxopropyl)-20-(3-carbamimidamidopropyl)-23-[(1R)-1-hydroxyethyl]-14-(1H-indol-3-ylmethyl)-7,13,16,19,22,25-hexaoxo-3,28-dithia-6,12,15,18,21,24,34-heptazatricyclo[28.3.1.08,12]tetratriaconta-1(33),30(34),31-triene-5-carbonyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-8-[(1R)-1-hydroxyethyl]-7,10-dioxo-3,13-dithia-6,9,19-triazabicyclo[13.3.1]nonadeca-1(18),15(19),16-triene-5-carbonyl]amino]-3-methylbutanoic acid
   Show/Hide
C90H129N25O26S4
 1
1
Ki = 2.7 nM
   TI
   LI
   LO
   TS
CP0580051
(3S,6S,9S,12S,15R,23R,26S)-15-[(2-aminoacetyl)amino]-6-(2-carboxyethyl)-9-[3-(diaminomethylideneamino)propyl]-12-[(1R)-1-hydroxyethyl]-3-[(4-hydroxyphenyl)methyl]-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosane-23-carboxylic acid
   Show/Hide
C40H59N11O14S2
 1
1
Ki = 3.2 nM
   TI
   LI
   LO
   TS
CP0951171
(3S,6S,9S,12S,15R,23R,26S)-15-[(2-aminoacetyl)amino]-6-(3-amino-3-oxo-propyl)-9-(3-guanidinopropyl)-12-[(1R)-1-hydroxyethyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosane-23-carboxylic acid
   Show/Hide
C42H61N13O12S2
 1
1
Ki = 3.6 nM
   TI
   LI
   LO
   TS
CP0970589
(3S,6S,9S,12S,15R,23R,26S)-15-[(2-aminoacetyl)amino]-6-(2-carboxyethyl)-9-(3-guanidinopropyl)-12-[(1R)-1-hydroxyethyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosane-23-carboxylic acid
   Show/Hide
C42H60N12O13S2
 1
1
Ki = 5.1 nM
   TI
   LI
   LO
   TS
CP0567917
(5R,8S,11S,14S,17S,20R)-20-[(2-aminoacetyl)amino]-11-(3-amino-3-oxopropyl)-14-[3-(diaminomethylideneamino)propyl]-17-[(1R)-1-hydroxyethyl]-7,10,13,16,19-pentaoxo-8-propan-2-yl-3,22-dithia-6,9,12,15,18,28-hexazabicyclo[22.3.1]octacosa-1(27),24(28),25-triene-5-carboxylic acid
   Show/Hide
C35H56N12O10S2
 1
1
Ki = 5.8 nM
   TI
   LI
   LO
   TS
CP0969875
(2S)-2-[[(5R,8S,11R)-11-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(5R,8S,11S,17S,20S,23S,26S,29S,32R)-17-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-32-[[(2S)-2-aminopropanoyl]amino]-26-(3-carbamimidamidopropyl)-23-(2-carboxyethyl)-29-[(1R)-1-hydroxyethyl]-20-[(4-hydroxyphenyl)methyl]-7,10,16,19,22,25,28,31-octaoxo-3,34-dithia-6,9,15,18,21,24,27,30,40-nonazatricyclo[34.3.1.011,15]tetraconta-1(39),36(40),37-triene-5-carbonyl]amino]propanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-8-(2-methylpropyl)-7,10-dioxo-3,13-dithia-6,9,19-triazabicyclo[13.3.1]nonadeca-1(18),15(19),16-triene-5-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoic acid
   Show/Hide
C96H137N29O27S4
 1
1
Ki = 6.1 nM
   TI
   LI
   LO
   TS
CP0569981
(5R,8S,11S,14S,17S,20R)-20-[(2-aminoacetyl)amino]-11-(2-carboxyethyl)-14-[3-(diaminomethylideneamino)propyl]-17-[(1R)-1-hydroxyethyl]-7,10,13,16,19-pentaoxo-8-propan-2-yl-3,22-dithia-6,9,12,15,18,28-hexazabicyclo[22.3.1]octacosa-1(27),24(28),25-triene-5-carboxylic acid
   Show/Hide
C35H55N11O11S2
 1
1
Ki = 6.4 nM
   TI
   LI
   LO
   TS
CP0550171
(2S)-4-amino-2-[[(5R,11S,14S,17S,20R)-5-[[(2S)-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(5R,8S,11S,14S,17S,20R)-20-[(2-aminoacetyl)amino]-11-(3-amino-3-oxopropyl)-14-(3-carbamimidamidopropyl)-17-[(1R)-1-hydroxyethyl]-7,10,13,16,19-pentaoxo-8-propan-2-yl-3,22-dithia-6,9,12,15,18,28-hexazabicyclo[22.3.1]octacosa-1(27),24(28),25-triene-5-carbonyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-14-(hydroxymethyl)-17-methyl-6,12,15,18-tetraoxo-3,22-dithia-7,13,16,19,28-pentazatricyclo[22.3.1.07,11]octacosa-1(28),24,26-triene-20-carbonyl]amino]-4-oxobutanoic acid
   Show/Hide
C85H129N27O26S4
 1
1
Ki = 7 nM
   TI
   LI
   LO
   TS
CP0954574
(5R,8S,11S,14S,17S,20R)-5-[(2-aminoacetyl)amino]-14-(2-carboxyethyl)-11-(3-guanidinopropyl)-8-[(1R)-1-hydroxyethyl]-17-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-3,22-dithia-7,10,13,16,19,28-hexazabicyclo[22.3.1]octacosa-1(27),24(28),25-triene-20-carboxylic acid
   Show/Hide
C41H56N12O11S2
 1
1
Ki = 10.8 nM
   TI
   LI
   LO
   TS
CP0578265
5-[2-[2-[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[2-[2-[2-[[(3S,6S,9S,12S,15R,23R,26S)-6-(3-amino-3-oxopropyl)-9-(3-carbamimidamidopropyl)-23-carbamoyl-12-[(1R)-1-hydroxyethyl]-3-[(4-hydroxyphenyl)methyl]-2,5,8,11,14,19,25-heptaoxo-17,21-dithia-1,4,7,10,13,24-hexazabicyclo[24.3.0]nonacosan-15-yl]amino]-2-oxoethoxy]ethoxy]ethylamino]-4-carboxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-(hexadecanoylamino)-1-oxohexan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-2-oxoethoxy]ethoxy]ethylcarbamoyl]-2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid
   Show/Hide
C131H178N22O41S2
 1
1
Ki = 23 nM
   TI
   LI
   LO
   TS
CP0954573
(2S)-1-[(3R,11R,14S,17S,20S,23S)-3-[[(3S,6S,9S,12S,15S,18R,26R,29S,32S,35S)-18-[[(2S)-2-amino-4-methylsulfanyl-butanoyl]amino]-9-(3-amino-3-oxo-propyl)-3-(carboxymethyl)-12-(3-guanidinopropyl)-15,32-bis(hydroxymethyl)-6-(1H-indol-3-ylmethyl)-29-isobutyl-2,5,8,11,14,17,22,28,31,34-decaoxo-20,24-dithia-1,4,7,10,13,16,27,30,33-nonazabicyclo[33.3.0]octatriacontane-26-carbonyl]amino]-20-(3-amino-3-oxo-propyl)-17-(3-guanidinopropyl)-14-[(1R)-1-hydroxyethyl]-2,7,13,16,19,22-hexaoxo-5,9-dithia-1,12,15,18,21-pentazabicyclo[21.3.0]hexacosane-11-carbonyl]pyrrolidine-2-carboxylic acid
   Show/Hide
C91H139N27O28S5
 1
1
Ki = 24 nM
   TI
   LI
   LO
   TS
CP0970167
(2S)-2-[[(3R,6S,9R)-9-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(3S,6S,9S,12S,15S,18R,26R,29S,32S)-3-(2-amino-2-oxo-ethyl)-29-(3-amino-3-oxo-propyl)-18-[[(2S)-2-aminopropanoyl]amino]-9-(2-carboxyethyl)-12-(3-guanidinopropyl)-15-[(1R)-1-hydroxyethyl]-6-[(4-hydroxyphenyl)methyl]-2,5,8,11,14,17,22,28,31-nonaoxo-20,24-dithia-1,4,7,10,13,16,27,30-octazabicyclo[30.3.0]pentatriacontane-26-carbonyl]amino]propanoyl]amino]-4-oxo-butanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoyl]amino]-6-isobutyl-5,8,13-trioxo-1,11-dithia-4,7-diazacyclotetradecane-3-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoic acid
   Show/Hide
C88H131N27O29S4
 1
1
Ki = 28 nM
   TI
   LI
   LO
   TS
CP0576840
(5R,8S,11S,14S,17S,20R)-20-[(2-aminoacetyl)amino]-11-(3-amino-3-oxopropyl)-14-[3-(diaminomethylideneamino)propyl]-17-(hydroxymethyl)-7,10,13,16,19-pentaoxo-8-propan-2-yl-3,22-dithia-6,9,12,15,18,28-hexazabicyclo[22.3.1]octacosa-1(27),24(28),25-triene-5-carboxylic acid
   Show/Hide
C34H54N12O10S2
 1
1
Ki = 29 nM
   TI
   LI
   LO
   TS
CP0970510
(5R,8S,11S,14S,17S,20R)-5-[(2-aminoacetyl)amino]-14-(3-amino-3-oxo-propyl)-11-(3-guanidinopropyl)-8-[(1R)-1-hydroxyethyl]-17-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-3,22-dithia-7,10,13,16,19,28-hexazabicyclo[22.3.1]octacosa-1(27),24(28),25-triene-20-carboxylic acid
   Show/Hide
C41H57N13O10S2
 1
1
Ki = 29 nM
   TI
   LI
   LO
   TS
CP0953197
(3S,6S,9S,12S,15S,18R,26R,29S)-18-[(2-aminoacetyl)amino]-9-(3-amino-3-oxo-propyl)-3-(carboxymethyl)-12-(3-guanidinopropyl)-15-[(1R)-1-hydroxyethyl]-6-(1H-indol-3-ylmethyl)-2,5,8,11,14,17,22,28-octaoxo-20,24-dithia-1,4,7,10,13,16,27-heptazabicyclo[27.3.0]dotriacontane-26-carboxylic acid
   Show/Hide
C46H66N14O15S2
 1
1
Ki = 79 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Kallikrein-5 (KLK5) )
Target Type Patented-recorded Target